Biparametric magnetic resonance imaging findings combined with prostate specific antigen density is a reliable factor to diagnose clinically significant prostate cancer

Bibliographic Details
Main Authors:	S. Sekito, T. Onishi, T. Terabe, T. Shibahara
Format:	Article
Language:	English
Published:	Elsevier 2020-07-01
Series:	European Urology Open Science
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666168320337460

Biparametric versus multiparametric magnetic resonance imaging of the prostate: detection of clinically significant cancer in a perfect match group
by: Jungheum Cho, et al.
Published: (2020-12-01)

Comparison of Sensitivity and Specificity of Biparametric versus Multiparametric Prostate MRI in the Detection of Prostate Cancer in 431 Men with Elevated Prostate-Specific Antigen Levels
by: Filippo Pesapane, et al.
Published: (2021-07-01)

The Utility of Combined Target and Systematic Prostate Biopsies in the Diagnosis of Clinically Significant Prostate Cancer Using Prostate Imaging Reporting and Data System Version 2 Based on Biparametric Magnetic Resonance Imaging
by: Daiki Kato, et al.
Published: (2021-03-01)

Diagnostic accuracy of ADC value on biparametric MRI for detecting clinically significant prostate cancer
by: J.H. Park, et al.
Published: (2020-07-01)

Comparison of biparametric and multiparametric MRI in the diagnosis of prostate cancer
by: Lili Xu, et al.
Published: (2019-12-01)

Investigating the equivalent performance of biparametric compared to multiparametric MRI in detection of clinically significant prostate cancer
by: W. Baojun, et al.
Published: (2020-07-01)

Non-invasive down-staging after transurethral resection of bladder tumor plus systemic chemotherapy is an optimal selection criteria for bladder-sparing strategy in muscle-invasive bladder cancer
by: T. Onishi, et al.
Published: (2020-07-01)

Biparametric MRI detects the aggressive molecular features of prostate cancer
by: J. Norris, et al.
Published: (2020-07-01)

Modified Predictive Model and Nomogram by Incorporating Prebiopsy Biparametric Magnetic Resonance Imaging With Clinical Indicators for Prostate Biopsy Decision Making
by: Jin-feng Pan, et al.
Published: (2021-09-01)

Autosegmentation of Prostate Zones and Cancer Regions from Biparametric Magnetic Resonance Images by Using Deep-Learning-Based Neural Networks
by: Chih-Ching Lai, et al.
Published: (2021-04-01)

Diagnostic accuracy of biparametric magnetic resonance imaging of the prostate (bp-MRI) in males who never underwent prostate biopsy: data after more than 350 patients enrolled
by: S. De Luca, et al.
Published: (2020-10-01)

Prostate-specific Antigen (PSA) Density and Free to Total PSA Ratio in Diagnosing Prostate Cancer with Prostate-Specific Antigen Levels of 4.0 ng/ml or Less
by: Xin LIU, et al.
Published: (2015-11-01)

Malakoplakia of the prostate diagnosed in patients with benign prostatic hyperplasia and elevated prostate-specific antigen
by: Fredy Leonardo Muñoz Gonzalez, et al.
Published: (2018-07-01)

Cancer Detection Rates of Systematic and Targeted Prostate Biopsies after Biparametric MRI
by: Maudy C. W. Gayet, et al.
Published: (2020-01-01)

Comparison between biparametric prostate MRI (bpMRI) and multiparametric MRI (mpMRI) in the detection of prostate cancer
by: A. Iseppi, et al.
Published: (2020-01-01)

The Efficiency of the Serum Prostate Specific Antigen Levels in Diagnosing Prostatic Enlargements
by: Ingle SP, et al.
Published: (2013-01-01)

Quantification of diffusion restriction on PI-RADS 3 lesion using biparametric MRI for detecting clinically significant prostate cancer
by: J.H. Park, et al.
Published: (2020-07-01)

The performance characteristics of prostate-specific antigen and prostate-specific antigen density in Chinese men
by: Jeremy YC Teoh, et al.
Published: (2017-01-01)

Value of Prostate-Specific Antigen and Prostate-Specific Antigen Density in Detection of Prostate Cancer in an Iranian Population of Men
by: Mahyar Ghafoori, et al.
Published: (2009-08-01)

Correlation between prostate volume, prostate specific antigen level, prostate specific antigen density and age in the benign prostate hyperplasia patients
by: Djoko Rahardjo, et al.
Published: (1999-10-01)

Improving workflow in prostate MRI: AI-based decision-making on biparametric or multiparametric MRI
by: Andreas M. Hötker, et al.
Published: (2021-08-01)

Prostate-specific antigen and prostate-specific antigen density cutoff points among Indonesian population suspected for prostate cancer
by: Ahmad Anies Shahab, et al.
Published: (2013-03-01)

Can Prostate-Specific Antigen Density Be an Index to Distinguish Patients Who Can Omit Repeat Prostate Biopsy in Patients with Negative Magnetic Resonance Imaging?
by: Yu J, et al.
Published: (2021-07-01)

Transition zone prostate cancer: Detection by second-look micro-ultrasonography after biparametric MRI
by: F. Cornud, et al.
Published: (2020-11-01)

Prostate-specific antigen and free prostate-specific antigen/prostate-specific antigen ratio in patients with benign prostatic hyperplasia and prostate cancer
by: Amal A. Hussein, et al.
Published: (2020-12-01)

Preoperative prostate biopsy and multiparametric magnetic resonance imaging: reliability in detecting prostate cancer
by: Francesco Porpiglia, et al.
Published: (2015-02-01)

Successful management of a fistula between an external iliac artery and an ileal conduit with endovascular embolization and vascular bypass
by: Sho Sekito, et al.
Published: (2020-01-01)

Comparison between biparametric and multiparametric MR imaging of Prostate Imaging Reporting and Data System Version 2.1 in detection of prostate cancer
by: Mohamed Ali EL-Adalany, et al.
Published: (2021-03-01)

Prostate-Specific Antigen Density: A Measurement to Differentiate Benign Hypertrophy of Prostate from Prostate Carcinoma
by: Chandan Kumar Nath, et al.
Published: (2020-03-01)

Age-specific prostate specific antigen and prostate specific antigen density values in a community-based Indian population
by: Arvind P Ganpule, et al.
Published: (2007-01-01)

Diagnosis value of prostate specific antigen density (PSAD) and prostate specific antigen (PSA) in bone metastases of prostate cancer among Indonesian population
by: Ahmad Zulfan Hendri, et al.
Published: (2020-05-01)

Machine learning methods can more efficiently predict prostate cancer compared with prostate-specific antigen density and prostate-specific antigen velocity
by: Satoshi Nitta, et al.
Published: (2019-09-01)

Serum prostate-specific antigen, radiologic findings and Gleason score in prostate biopsies in Jordan
by: Mohammed G. Abu Farsakh, et al.
Published: (2008-07-01)

Diagnostic performance of biparametric prostate MRI in the detection of prostate cancer: focus on role of PSA, tumor volume and ADC in PI-RADS >= 4 nodules
by: A. Iseppi, et al.
Published: (2020-01-01)

Multiparametric magnetic resonance imaging findings of prostatic pure leiomyomas
by: Thais Caldara Mussi, et al.

Diagnostic Performance of PI-RADS v2, Proposed Adjusted PI-RADS v2 and Biparametric Magnetic Resonance Imaging for Prostate Cancer Detection: A Preliminary Study
by: Guan-Hui Cai, et al.
Published: (2021-05-01)

Evaluation of the Prostate Imaging Reporting and Data System for Magnetic Resonance Imaging Diagnosis of Prostate Cancer in Patients with Prostate-specific Antigen <20 ng/ml
by: Xuan Wang, et al.
Published: (2016-01-01)

Clinical significance of the LacdiNAc-glycosylated prostate-specific antigen assay for prostate cancer detection
by: T. Yoneyama, et al.
Published: (2020-07-01)

Co-expression and impact of prostate specific membrane antigen and prostate specific antigen in prostatic pathologies
by: Nouira Yassin, et al.
Published: (2010-12-01)

Diagnostic performance of biparametric MRI of the prostate (bp-MRI) in biopsy-naïve men with suspect of prostate cancer: Intermediate data of a phase II study
by: S. De Luca, et al.
Published: (2020-07-01)

Biparametric magnetic resonance imaging findings combined with prostate specific antigen density is a reliable factor to diagnose clinically significant prostate cancer

Similar Items

Similar Items